Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …

Cancer cells can induce an immunological response resulting in the production of tumor-
associated (TA) autoantibodies. These serum immunobiomarkers have been detected for a …

Tumor-associated autoantibodies (AAbs) have been described in patients with lung cancer,
and the Early CDT®-Lung test that measures such AAbs is available as an aid for the early …

Background Autoantibodies may be present in a variety of underlying cancers several years
before tumours can be detected and testing for their presence may allow earlier diagnosis …

Abstract Objectives EarlyCDT®-Lung may enhance detection of early stage lung cancer by
aiding physicians in assessing high-risk patients through measurement of biological …

Recent publications have reported the technical and clinical validation of Early CDT-Lung,
an autoantibody test which detected elevated autoantibodies in 40% of lung cancers at …

Abstract Objectives “PAULA's” test (P rotein A ssays U tilizing L ung cancer A nalytes) is a
novel multiplex immunoassay blood test that incorporates both tumor antigens and …

Objective We performed a comprehensive review and meta-analysis to evaluate the
diagnostic values of serum single and multiplex tumor-associated autoantibodies (TAAbs) in …

Introduction The incidence of pulmonary nodules is increasing with the movement toward
screening for lung cancer by low-dose computed tomography. Given the large number of …

Objective: To establish whether improved tumor survival in patients with Lambert-Eaton
myasthenic syndrome (LEMS) and small-cell lung cancer (SCLC) was due to known …